Description

This webinar will provide healthcare professionals with a practical approach to identifying and managing hypercortisolism, with a focus on its key comorbidities and impact on glycemic control. Through real-world case studies, attendees will learn to apply clinical guidelines for screening and diagnosis, incorporating targeted strategies to optimize patient outcomes.

The session will explore three compelling cases:
• Progressive Hyperglycemia in Challenging Type 2 Diabetes (T2D)
• Adrenal Adenoma and Worsening Glycemic Control
• Newly Diagnosed T2D with Potential Cortisol Involvement

This webinar is the second in a two-part series. Register for part 1, "The Overlooked Connection – Why You Should Screen for Hypercortisolism in Type 2 Diabetes," here: adces.org/product/WEBC250429

Before joining this live webinar, we encourage you to view this recorded webinar from October 2024, "A Closer Look at Difficult-to-Manage Diabetes – Is Cortisol at Play?" here: adces.org/product/WEBC241022

Learning Objectives

After watching this webinar, you'll be able to:
-- Identify key comorbidities associated with hypercortisolism.
-- Apply clinical guidelines for screening and diagnosing hypercortisolism.
-- Incorporate judicious screening strategies into clinical practice to optimize patient outcomes.

Sponsor

This webinar is sponsored by Corcept Therapeutics.

Intended Audience

This activity is designed for diabetes care and education specialists, including nurses, dietitians, pharmacists, PAs, physicians, and other health care providers interested in staying up to date on current practices of care for people with diabetes and other related conditions.

Disclaimer

There is no CE/CME credit for this activity.

Faculty

Natalie J. Bellini, DNP, FNP-BC, BC-ADM, CDCES
Assistant Professor of Medicine
Case Western Reserve University
Program Director, Diabetes Technology
University Hospitals Diabetes and Metabolic Care Center

Natalie J. Bellini, DNP, FNP-BC, BC-ADM, CDCES is an Endocrine Nurse Practitioner and Program Director of Technology at University Hospitals and Faculty Advisor for Close Concerns. Dr. Bellini earned her Bachelor's degree in Nursing from Drexel University and Family Nurse Practitioner and Doctor of Nursing Practice from D'Youville University. Dr. Bellini holds board certifications as a family nurse practitioner and in advanced diabetes management. She has published studies on topics including the use of GLP-1 agonists in patients with type 1 diabetes and using technology in diabetes management. She has been a speaker nationally and internationally regarding diabetes management and the impact of technology on diabetes care and outcomes.

As a faculty member for Close Concerns, Dr. Bellini works with the associates to bring perspective as a patient and a clinician to data and outcomes presented at conferences and earnings reports. She co-hosts podcast Diabetes Dialogue: Technology, Therapeutics, & Real Word Perspectives with colleague Dr. Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES.

Davida F. Kruger, MSN, APN-BC, BC-ADM
Nurse Practitioner
Henry Ford Medical Center New Center One
Henry Ford Health System

Davida F. Kruger is a certified nurse practitioner in the Division of Endocrinology at Henry Ford Health System in Detroit, Michigan, where she is involved in both clinical practice and research. She is board certified by the American Nurses Association Credentialing Center in Primary Care, and by the American Association of Diabetes Educators in Advanced Diabetes Management. She is past chair of the American Diabetes Association (ADA) Research Foundation and has served on the ADA's Research Policy Committee. She is also a past president of Health Care and Education for the ADA.

Davida was the Editor of Diabetes Spectrum from 2005-2008 and Editor In Chief of Clinical Diabetes from 2011-2016. She was the Clara Ford Award for Nursing Excellence in Research and Education in 2014 as well as the Alumna of the Year Award from Wayne State University School of Nursing in that same year. Davida has also received the Florence Nightingale Award for Excellence in Research, Rachmeil Levine Award for Distinguished Service, Ross Hickey Award for Outstanding Service in Diabetes Research Funding, and Wendell Mayes, Jr. Medal for Outstanding Service in the Cause of Diabetes.